CONGENITAL LIVER-DAMAGE AFTER TREATMENT OF MOTHER WITH VALPROIC ACID AND PHENYTOIN

被引：12

作者：

FELDING, I ^{[1
]}

RANE, A ^{[1
]}

机构：

[1] HUDDINGE UNIV HOSP, KAROLINSKA INST, DEPT CLIN PHARMACOL, S-14186 HUDDINGE, SWEDEN

来源：

ACTA PAEDIATRICA SCANDINAVICA | 1984年 / 73卷 / 04期

关键词：

D O I：

10.1111/j.1651-2227.1984.tb09974.x

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：565 / 568

页数：4

共 22 条

[1]

BJERKEDAL T, 1982, LANCET, V2, P1096

[2]

BROWN NA, 1980, LANCET, V1, P660

[3] DECREASED PLASMA-PROTEIN BINDING OF PHENYTOIN IN PATIENTS ON VALPROIC ACID [J].

DAHLQVIST, R ;

BORGA, O ;

RANE, A ;

WALSH, Z ;

SJOQVIST, F .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (06) :547-552

[4] TERATOGENICITY OF VALPROIC ACID [J].

DALENS, B ;

RAYNAUD, EJ ;

GAULME, J .

JOURNAL OF PEDIATRICS, 1980, 97 (02) :332-333

[5]

DONAT JF, 1979, NEUROLOGY, V29, P273

[6] INCREASED ORAL CLEARANCE OF METOPROLOL IN PREGNANCY [J].

HOGSTEDT, S ;

LINDBERG, B ;

RANE, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (02) :217-220

[7]

HOJER B, 1982, DEV MED CHILD NEUROL, V24, P846

[8]

Hoshino M, 1972, MED PROG, V82, P470

[9]

KAO J, 1981, Teratogenesis Carcinogenesis and Mutagenesis, V1, P367, DOI 10.1002/tcm.1770010405

[10]

LEBIHAN G, 1980, LANCET, V2, P1298

← 1 2 3 →